Jakafi Tablets 10mg In Pakistan
Jakafi 10mg Tablets contain ruxolitinib, a Janus kinase (JAK) inhibitor used to treat certain blood disorders and immune-related conditions. It works by blocking JAK1 and JAK2 enzymes, helping to reduce abnormal blood cell production and control disease-related symptoms.
Jakafi 10mg is prescribed for adults with intermediate or high-risk myelofibrosis, including primary myelofibrosis and myelofibrosis associated with polycythemia vera or essential thrombocythemia. It is also used for adults with polycythemia vera who have not responded adequately to or cannot tolerate hydroxyurea. Additionally, it may be prescribed for certain cases of acute and chronic graft-versus-host disease (GVHD).
Key Points:
Active Ingredient: Ruxolitinib 10mg
Form: Oral tablet
Therapeutic Class: Janus Kinase (JAK) inhibitor
Prescription: Required
Common Side Effects: Anemia, low platelets, bruising, headache, dizziness, diarrhea, and increased infection risk